House of Commons - Science and Technology - Appendices to the Minutes of Evidence

House of Commons portcullis

House of Commons

Session 1999-2000
Publications on the internet
Science and Technology Committee Publications

Science and Technology - Appendices to the Minutes of Evidence [Back to Report]

Here you can browse the Appendices to the Minutes of Evidence which were ordered by the House of Commons to be printed 25 July 2000.

CONTENTS

APPENDIX 1

Memorandum submitted by Professors Will Steward and Mr Andy Gescher, Department of Oncology and MRC Toxicology Unit, University of Leicester

APPENDIX 2

Memorandum submitted by the Pelican Centre

APPENDIX 3

Memorandum submitted by Dr Nicholas Summerton, University of Hull/Winterton Medical Practice

APPENDIX 4

Memorandum submitted by the British Association for Cancer Research

APPENDIX 5

Memorandum submitted by Dr Ann Johnson, Breast Study Centre, Mount Vernon Hospital, Northwood

APPENDIX 6

Letter to the Clerk of the Committee from the Joint Collegiate Committee for Oncology

APPENDIX 7

Memorandum submitted by the GersonTM Support Group

APPENDIX 8

Memorandum submitted by Professor Terry Hamblin, Professor of Immunohaematology, Southampton University

APPENDIX 9

Memorandum submitted by Mr Leslie E F Moffat, Immediate Past Chairman, MRC Working Party in Prostate Cancer

APPENDIX 10

Memorandum submitted by The Breast Cancer Campaign

Attachment 1

APPENDIX 11

Memorandum submitted by the Leukaemia Research Fund

Annex 1

APPENDIX 12

Letter to the Clerk of the Committee from Professor Julian Peto, Head of Section of Epidemiology, and Sir Richard Doll, Emeritus Professor, Oxford University, the Institute of Cancer Research

APPENDIX 13

Memorandum submitted by Digene Europe

APPENDIX 14

Memorandum submitted by Marie Curie Cancer Care

APPENDIX 15

Memorandum submitted by Macmillan Cancer Relief

Annex I

APPENDIX 16

Memorandum submitted by the United Kingdom Co-ordinating Committee on Cancer Research

APPENDIX 17

Memorandum submitted by Professor Norman J Maitland, Director YCR Cancer Research Unit, University of York

APPENDIX 18

Memorandum submitted by The Earl Baldwin of Bewdley

APPENDIX 19

Memorandum submitted by The Wellcome Trust

Annex 1
Annex 2
Annex 3

APPENDIX 20

Memorandum Submitted by the Prostate Cancer Charity

APPENDIX 21

Memorandum submitted by the University of Manchester, the Christie Hospital NHS Trust and the Paterson Institute for Cancer Research

APPENDIX 22

Memorandum submitted by the Royal Pharmaceutical Society of Great Britain

APPENDIX 23

Letter to the Clerk of the Committee from Mr David J Waldron, Managing Director, Marconi Medical Systems UK Ltd

Memorandum submitted by Marconi Medical Systems UK Ltd

APPENDIX 24

Letter to the Clerk of the Committee from Dr Peter Rigby, Chief Executive, Institute of Cancer Research and Miss Cally Palmer, Chief Executive, Royal Marsden NHS Trust

Memorandum submitted by the Institute of Cancer Research and The Royal Marsden NHS Trust

Annex 1

APPENDIX 25

Letter to the Clerk of the Committee from Mrs Helen Remington, Chief Pharmacist, Pharmacy Department, and Dr Pippa Corrie, Consultant Medical Oncologist, Oncology Department, Addenbrooke's NHS Trust, Cambridge

Annex 1

APPENDIX 26

Memorandum submitted by the London School of Hygiene and Tropical Medicine

APPENDIX 27

Memorandum submitted by the Health and Safety Executive

Annex 1
Annex 2

APPENDIX 28

Memorandum submitted by Breakthrough Breast Cancer

APPENDIX 29

Letter to the Committee Specialist from Professor C R W Edwards, Principal, Imperial College School of Medicine

APPENDIX 30

Memorandum submitted by the Biotechnology and Biological Sciences Research Council

APPENDIX 31

Letter to the Clerk of the Committee from Tenovus

APPENDIX 32

Letter to the Committee Specialist from Mr Leslie E F Moffat, Editor-in-Chief, UroOncology

APPENDIX 33

Letter to the Clerk of the Committee from Professor John S Smyth, Professor of Medical Oncology, University of Edinburgh, and Director, Imperial Cancer Research Fund.

APPENDIX 34

Memorandum submitted by Professor E S Newlands, Trophoblastic Tumour Screening and Treatment Centre, Charing Cross Hospital

APPENDIX 35

Memorandum submitted by Nycomed Amersham plc

Annex 1

APPENDIX 36

Memorandum submitted by Professor Stanley Brown, Yorkshire Cancer Research Professor, University of Leeds

APPENDIX 37

Memorandum submitted by Professor A G Dalgleish, St George's Hospital Medical School

APPENDIX 38

Memorandum submitted by Professor Emeritus James Spencer Malpas, University of London

APPENDIX 39

Memorandum submitted by the Office of Science and Technology

APPENDIX 40

Letter to the Committee Specialist from Professor W P Steward, Head of Department of Oncology, University of Leicester

APPENDIX 41

Letter to the Clerk of the Committee from Professor S B Kaye, Professor of Medical Oncology, CRC Department of Medical Oncology, University of Glasgow

APPENDIX 42

Letter to the Clerk of the Committee from Mr John A Peel, Managing Director, Varian Medical Systems UK Ltd

APPENDIX 43

Letter to the Committee Specialist from Professor A L Harris, Director, ICRF Medical Oncology Unit, University of Oxford

APPENDIX 44

Memorandum submitted by Professor David J Kerr, Professor of Clinical Oncology, CRC Institute for Cancer Studies, University of Birmingham

APPENDIX 45

Memorandum submitted by Professor Hilary Thomas, Professor of Oncology, University of Surrey and the Royal Surrey County Hospital

APPENDIX 46

Letter to the Clerk of the Committee from Professor A J P Dalton, consultant, researcher and writer on environmental and occupational hazards

APPENDIX 47

Letter to the Committee Specialist from Dr Camilo Colaco, Managing Director, ImmunoBiology Limited

APPENDIX 48

Memorandum submitted by the Academic Department of Oncology, School of Medicine, Faculty of Health, University of Hull

APPENDIX 49

Memorandum submitted by Professor Alan K Burnett, on behalf of the MRC Adult Leukaemia Working Party, University of Wales

APPENDIX 50

Letter to the Clerk of the Committee from Professor Sir George Radda, CBE FRS, Chief Executive, Medical Research Council

Annex 1
Annex 2

APPENDIX 51

Letter to the Clerk of the Committee from Mr Neville Teller, Macmillan Cancer Relief

APPENDIX 52

Letter to the Clerk of the Committee from Dr Richard Tiner, Medical Director, the Association of the British Pharmaceutical Industry

Annex

APPENDIX 53

Memorandum submitted by the Academy of Medical Sciences

APPENDIX 54

Letter to the Clerk of the Committee from Ms Elizabeth A Wilson, Chairman, Stranraer Cancer Drop In Centre Association

APPENDIX 55

Letter to the Clerk of the Committee from Ms Karen Meehan, Derry Well Woman

Living With Cancer

A Charter for People With Cancer

APPENDIX 56

Letter to the Clerk of the Committee from Dr Ellen C G Grant

APPENDIX 57

Memorandum submitted by Guy's and St Thomas' Hospital Trust

APPENDIX 58

Supplementary memorandum submitted by Professor Emeritus James Spencer Malpas, University of London Letter to the Clerk of the Committee

APPENDIX 59

Letter to the Chairman of the Committee from Dr Ian Smith, Professor of Cancer Medicine and Medical Director, The Royal Marsden NHS Trust

APPENDIX 60

Letter to the Clerk of the Committee from Mr Iain Bourne, Compliance Manager (Health), Data Protection

APPENDIX 61

Letter to the Committee Specialist from the Parliamentary Clerk, Department of Health, following the Evidence Session of 22 March

APPENDIX 62

Memorandum submitted by Mr Graham Lewington, Business Development Manager, Mobile PET Systems (UK) Ltd

APPENDIX 63

Letter from the Committee Specialist from Professor Bruce Ponder, Professor of Oncology, University of Cambridge

© Parliamentary copyright 2000
Prepared 28 July 2000